Evidence mapPaperPMID 21262010Full record

ReviewNederlands tijdschrift voor geneeskunde2011

[Cholesterol homeostasis and enterohepatic connection: new insights in cholesterol absorption].

Boudewijn Klop, Jan Willem F Elte, Manuel Castro Cabezas

Registry-linked trialAbstract readReview
PubMed
In one paragraph

Review in Nederlands tijdschrift voor geneeskunde, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01634906 (Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01634906 nacompletedstarted 2012, after this paper: background citation

Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy

Ran2012Enrolled55Registered outcomes3Posted comparisons0ConditionsAtherosclerosis, HyperlipidemiaArmsTemporary discontinuation of statin therapy
Open the trial in the graph
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Boudewijn KlopSint Franciscus Gasthuis, afd. Interne Geneeskunde, Rotterdam, the Netherlands. b.klop@sfg.nl
Jan Willem F Elte
Manuel Castro Cabezas
Sint Franciscus Gasthuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestines have been proposed as the 'new player' in the field of atherosclerosis as a result of recent discoveries on intestinal cholesterol absorption and excretion. 'Niemann-Pick C1-like 1' is one of the most important transport proteins in the process of intestinal and biliary cholesterol absorption. Cholesterol is not only excreted via the hepato-biliary route but is also excreted directly into the intestinal lumen; this transintestinal cholesterol excretion is particularly important in mice. Other cholesterol transporters have also been identified, including the ABC transporters, which have been linked to rare disorders such as sitosterolemia. Inhibition of intestinal cholesterol absorption increases the hepatic synthesis of cholesterol and vis versa; several different genes and hormones play an important role in this process. When the effect of statins is insufficient or they cause too many side-effects, additional inhibition of intestinal cholesterol absorption is indicated.

Indexed as

Anticholesteremic AgentsCholesterolHumansHypercholesterolemiaIntestinal AbsorptionMembrane ProteinsMembrane Transport ProteinsNiemann-Pick DiseasesAnticholesteremic AgentsCholesterolMembrane ProteinsMembrane Transport ProteinsNPC1L1 protein, human

Identifiers

PMID21262010
OpenAlexW188222181

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.